Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of sensitive indicators in immune response for leprosy affected patients: An observational clinical study of safety and immunogenicity of influenza vaccine. | Medicine (Baltimore) | 2021 | 34397815 | PubTator, text mining | PubMed |
| Divalent Metal Transporter 1 Knock-Down Modulates IL-1β Mediated Pancreatic Beta-Cell Pro-Apoptotic Signaling Pathways through the Autophagic Machinery. | Int J Mol Sci | 2021 | 34360779 | PubTator, text mining | PubMed |
| Receptor-Interacting Serine/Threonine-Protein Kinase-2 as a Potential Prognostic Factor in Colorectal Cancer. | Medicina (Kaunas) | 2021 | 34356990 | PubTator, text mining | PubMed |
| Crosstalks between NOD1 and Histone H2A Contribute to Host Defense against Streptococcus agalactiae Infection in Zebrafish. | Antibiotics (Basel) | 2021 | 34356784 | PubTator, text mining | PubMed |
| The E3 ubiquitin ligase RNF186 and RNF186 risk variants regulate innate receptor-induced outcomes. | Proc Natl Acad Sci U S A | 2021 | 34353900 | PubTator, text mining | PubMed |
| Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms. | ACS Cent Sci | 2021 | 34345664 | PubTator, text mining | PubMed |
| Induction of interferon response by high viral loads at early stage infection may protect against severe outcomes in COVID-19 patients. | Sci Rep | 2021 | 34344959 | PubTator, text mining | PubMed |
| Pattern recognition receptors in health and diseases. | Signal Transduct Target Ther | 2021 | 34344870 | PubTator, text mining | PubMed |
| Alterations in mitochondrial morphology as a key driver of immunity and host defence. | EMBO Rep | 2021 | 34337844 | PubTator, text mining | PubMed |
| Virulence of Trypanosoma cruzi Strains Is Related to the Differential Expression of Innate Immune Receptors in the Heart. | Front Cell Infect Microbiol | 2021 | 34336720 | PubTator, text mining | PubMed |
| Identification of covalent modifications regulating immune signaling complex composition and phenotype. | Mol Syst Biol | 2021 | 34318608 | PubTator, text mining | PubMed |
| Ligase Pellino3 Regulates Macrophage Action and Survival in Response to VSV Infection in RIG-I-Dependent Path. | Oxid Med Cell Longev | 2021 | 34306313 | PubTator, text mining | PubMed |
| Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis. | Front Immunol | 2021 | 34305919 | PubTator, text mining | PubMed |
| Knockdown of Mitogen-Activated Protein Kinase Kinase 3 Negatively Regulates Hepatitis A Virus Replication. | Int J Mol Sci | 2021 | 34299039 | PubTator, text mining | PubMed |
| The effects of genetic polymorphisms on benzene-exposed workers: A systematic review. | Health Sci Rep | 2021 | 34295994 | PubTator, text mining | PubMed |
| S-palmitoylation of NOD2 controls its localization to the plasma membrane. | J Lipid Res | 2021 | 34293401 | PubTator, text mining | PubMed |
| Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy. | Front Chem | 2021 | 34291036 | PubTator, text mining | PubMed |
| Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review). | Mol Med Rep | 2021 | 34278470 | PubTator, text mining | PubMed |
| NOD2 deficiency confers a pro-tumorigenic macrophage phenotype to promote lung adenocarcinoma progression. | J Cell Mol Med | 2021 | 34268854 | PubTator, text mining | PubMed |
| DNA-Encoded Library Hit Confirmation: Bridging the Gap Between On-DNA and Off-DNA Chemistry. | ACS Med Chem Lett | 2021 | 34267887 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=38